Bone Marrow Necrosis in A Male Patient with Anti-Phospholipid Syndrome: A Case Report with Literature Review

Downloads

Authors

  • Malak Hassan Faculty of Medicine, Alexandria University, Alexandria, Egypt https://orcid.org/0000-0002-1164-5002
    Competing Interests

    None

  • Maram Badra Department of Internal Medicine, Faculty of Medicine, Alexandria University, Egypt https://orcid.org/0009-0007-1718-0748
    Competing Interests

    None

  • Mina Soryal Department of Internal Medicine, Faculty of Medicine, Alexandria University, Egypt https://orcid.org/0009-0005-3705-8905
    Competing Interests

    None

  • Nooran Soror Department of Internal Medicine, Faculty of Medicine, Alexandria University, Egypt
    Competing Interests

    None

  • Ahmed Hisham Abdulfattah Department of Clinical Pathology, Faculty of Medicine, Alexandria University, Egypt
    Competing Interests

    None

  • Dalia Ahmed Nafea Department of Internal Medicine, Faculty of Medicine, Alexandria University, Egypt
    Competing Interests

    None

DOI:

https://doi.org/10.71079/ASIDE.CR.081725124

Abstract

Anti-phospholipid syndrome (APS) is a systemic autoimmune disease causing arterial and venous thrombosis, leading to macrovascular and microvascular complications. Bone marrow necrosis (BMN) is defined as the death of hematopoietic tissue and the loss of fat cells in a bone marrow biopsy. BMN is typically associated with a poor prognosis, with most patients dying within weeks. We present a case of BMN in a 32-year-old male patient with APS admitted to our hospital. The patient presented with bilateral non-healing leg ulcers and bilateral lower limb edema. The findings of the duplex ultrasound were consistent with old bilateral deep vein thromboses in the calves. The presence of acute kidney injury and proteinuria prompted a renal biopsy, which revealed chronic thrombotic microangiopathy. Bone marrow biopsy revealed BMN. Unfortunately, the patient did not respond to immunosuppressive treatment and passed away due to septic shock. The unique features in the patient’s presentation, combined with the availability of extensive data on the patient’s history and investigations, further enhance its significance. It is not possible to establish a cause-and-effect relationship or draw conclusive findings from this case report alone. More case reports from clinicians who come across BMN in patients with APS are needed to broaden our understanding of the pathogenesis, presentation, management, and outcomes.

Keywords:

bone marrow necrosis, anti-phospholipid syndrome, Case report

References

1. Truglia S, Capozzi A, Mancuso S, Manganelli V, Rapino L, Riitano G, Recalchi S, Colafrancesco S, Ceccarelli F, Garofalo T, Alessandri C, Longo A, Misasi R, Conti F, Sorice M. Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome. Front Immunol. 2022: 932181 [PMID: 35860235, https://doi.org/10.3389/fimmu.2022.932181] DOI: https://doi.org/10.3389/fimmu.2022.932181

2. Sammaritano LR. Antiphospholipid syndrome. Best Pract Res Clin Rheumatol. 2020: 101463 [PMID: 31866276, https://doi.org/10.1016/j.berh.2019.101463] DOI: https://doi.org/10.1016/j.berh.2019.101463

3. Bustamante JG, Goyal A, Rout P, Singhal M. Antiphospholipid Syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing

Copyright © 2025, StatPearls Publishing LLC.; 2025.

4. Gaspar P, Sciascia S, Tektonidou MG. Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations. Rheumatology (Oxford). 2024: SI24 [PMID: 38320589, https://doi.org/10.1093/rheumatology/kead571] DOI: https://doi.org/10.1093/rheumatology/kead571

5. Vandevelde A, Devreese KMJ. Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances. J Clin Med. 2022: [PMID: 35456258, https://doi.org/10.3390/jcm11082164] DOI: https://doi.org/10.3390/jcm11082164

6. Garcia D, Erkan D. Diagnosis and Management of the Antiphospholipid Syndrome. N Engl J Med. 2018: 2010 [PMID: 29791828, https://doi.org/10.1056/NEJMra1705454] DOI: https://doi.org/10.1056/NEJMra1705454

7. Cohen H, Cuadrado MJ, Erkan D, Duarte-Garcia A, Isenberg DA, Knight JS, Ortel TL, Rahman A, Salmon JE, Tektonidou MG, Williams DJ, Willis R, Woller SC, Andrade D. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Lupus. 2020: 1571 [PMID: 33100166, https://doi.org/10.1177/0961203320950461] DOI: https://doi.org/10.1177/0961203320950461

8. Luan C, Zhao H, Ding Y. Bone marrow necrosis: Facts, controversies, and perspective. Int J Lab Hematol. 2024: 770 [PMID: 38923828, https://doi.org/10.1111/ijlh.14335] DOI: https://doi.org/10.1111/ijlh.14335

9. Conrad ME. Bone marrow necrosis. J Intensive Care Med. 1995: 171 [PMID: 10155181, https://doi.org/10.1177/088506669501000403] DOI: https://doi.org/10.1177/088506669501000403

10. Wool GD, Deucher A. Bone marrow necrosis: ten-year retrospective review of bone marrow biopsy specimens. Am J Clin Pathol. 2015: 201 [PMID: 25596246, https://doi.org/10.1309/AJCP0TN1MCMOLMPK] DOI: https://doi.org/10.1309/AJCP0TN1MCMOLMPK

11. Badar T, Shetty A, Bueso-Ramos C, Cortes J, Konopleva M, Borthakur G, Pierce S, Huang X, Chen HC, Kadia T, Daver N, Dinardo C, O'Brien S, Garcia-Manero G, Kantarjian H, Ravandi F. Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome. Am J Hematol. 2015: 769 [PMID: 26017166, https://doi.org/10.1002/ajh.24074] DOI: https://doi.org/10.1002/ajh.24074

12. Bulvik S, Aronson I, Ress S, Jacobs P. Extensive bone marrow necrosis associated with antiphospholipid antibodies. Am J Med. 1995: 572 [PMID: 7778573, https://doi.org/10.1016/s0002-9343(99)80016-3] DOI: https://doi.org/10.1016/S0002-9343(99)80016-3

13. Paydas S, Kocak R, Zorludemir S, Baslamisli F. Bone marrow necrosis in antiphospholipid syndrome. J Clin Pathol. 1997: 261 [PMID: 9155683, https://doi.org/10.1136/jcp.50.3.261] DOI: https://doi.org/10.1136/jcp.50.3.261

14. Morad CS, Fayez D, Mahmoud M, Aboud FM. Primary and secondary antiphospholipid syndrome characteristics in an Egyptian cohort. The Egyptian Rheumatologist. 2022: 373 https://doi.org/10.1016/j.ejr.2022.07.006] DOI: https://doi.org/10.1016/j.ejr.2022.07.006

15. El-Moniem GA, El-Garf K, Sobhy N, Elmaghraby S. Characterization of the Clinical and Laboratory Features of Primary and Secondary Antiphospholipid Syndrome in a Cohort of Egyptian Patients. Curr Rheumatol Rev. 2020: 304 [PMID: 31951187, https://doi.org/10.2174/1573397116666200116095734] DOI: https://doi.org/10.2174/1573397116666200116095734

16. Elgamal BM, Rashed RA, Raslan HN. Prevalence of bone marrow necrosis in Egyptian cancer patients referring to the National Cancer Institute. J Egypt Natl Canc Inst. 2011: 95 [PMID: 22776813, https://doi.org/10.1016/j.jnci.2011.09.007] DOI: https://doi.org/10.1016/j.jnci.2011.09.007

17. Deucher A, Wool GD. How I investigate bone marrow necrosis. Int J Lab Hematol. 2019: 585 [PMID: 31424633, https://doi.org/10.1111/ijlh.13091] DOI: https://doi.org/10.1111/ijlh.13091

18. Cabral TCS, Fernandes CM, Lage LAC, Zerbini MC, Pereira J. Bone marrow necrosis: literature review. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2016: https://doi.org/10.5935/1676-2444.20160031] DOI: https://doi.org/10.5935/1676-2444.20160031

Data Availability Statement

The data supporting the findings of this case report are included within the article and its supplementary materials. Additional de-identified information may be made available upon reasonable request from the corresponding author.

Downloads

Share this article

Published

2025-08-17

Issue

Section

Case Report

Categories

How to Cite

1.
Hassan M, Badra M, Soryal M, Soror N, Abdulfattah AH, Nafea DA. Bone Marrow Necrosis in A Male Patient with Anti-Phospholipid Syndrome: A Case Report with Literature Review. ASIDE Case Reports. 2025;2(1):6-10. doi:10.71079/ASIDE.CR.081725124

Article history

Received
27 May 2025
Received in revised form
19 Jul 2025
Accepted
27 Jul 2025
Published
17 Aug 2025